PuSH - Publication Server of Helmholtz Zentrum München

23 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Diets, I.J.* et al.: De novo and inherited pathogenic variants in KDM3B cause intellectual disability, short stature, and facial dysmorphism. Am. J. Hum. Genet. 104, 758-766 (2019)
2.
Kröner, C.* et al.: Lung disease in STAT3 hyper-IgE syndrome requires intense therapy. Allergy, accepted (2019)
3.
Griese, M.* et al.: International management platform for children's interstitial lung disease (chILD-EU). Thorax 73, 231-239 (2018)
4.
Witt, S. et al.: Medication for childhood interstitial lung diseases differs internationally. Eur. Respir. J. 52 (2018)
5.
Xu, Z.* et al.: Bi-allelic mutations in Phe-tRNA synthetase associated with a multi-system pulmonary disease support non-translational function. Am. J. Hum. Genet. 103, 100-114 (2018)
6.
Szentes, B.L. et al.: Current practice of drug treatment in children with ILD: First insights from the child-EU registry. Value Health 19, A558-A558 (2016)
7.
Griese, M.* et al.: Surfactant lipidomics in healthy children and childhood interstitial lung disease. PLoS ONE 10:e0117985 (2015)
8.
Marcos, V.* et al.: Free DNA in cystic fibrosis airway fluids correlates with airflow obstruction. Mediators Inflamm. 2015:408935 (2015)
9.
Griese, M.* et al.: Inhalation treatment with glutathione in patients with cystic fibrosis. A randomized clinical trial. Am. J. Respir. Crit. Care Med. 188, 83-89 (2013)
10.
Hector, A.* et al.: Expression and regulation of interferon-related development regulator-1 in cystic fibrosis neutrophils. Am. J. Respir. Cell Mol. Biol. 48, 71-77 (2013)
11.
Kormann, M.S.* et al.: CXCR1 and CXCR2 haplotypes synergistically modulate cystic fibrosis lung disease. Eur. Respir. J. 39, 1385-1390 (2012)
12.
Hector, A.* et al.: The chitinase-like protein YKL-40 modulates cystic fibrosis lung disease. PLoS ONE 6:e24399 (2011)
13.
Hartl, D. et al.: Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases. J. Immunol. 181, 8053-8067 (2008)
14.
Hartl, D.* et al.: Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. J. Nat. Med. 13, 1423-1430 (2007)
15.
Hartl, D.* et al.: Quantitative and functional impairment of pulmonary CD4⁺CD25hi regulatory T cells in pediatric asthma. J. Allergy Clin. Immunol. 119, 1258-1266 (2007)
16.
Hartl, D.* et al.: Chemokines indicate allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 173, 1370-1376 (2006)
17.
Hartl, D.* et al.: Pulmonary Th2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. J. Allergy Clin. Immunol. 117, 204-211 (2006)
18.
Hartl, D.* et al.: A role for MCP-I/CCR2 in interstitial lung disease in children. Respir. Res. 6, 93-104 (2005)
19.
Hartl, D.* et al.: Pulmonary chemokines and their receptors differentiate children with asthma and chronic cough. J. Allergy Clin. Immunol. 115, 728-736 (2005)
20.
Griese, M.* et al.: Improvement of alveolar glutathione and lung function but not oxidative state in cystic fibrosis. Am. J. Respir. Crit. Care Med. 169, 822-828 (2004)